Location History:
- Boston, MA (US) (2019)
- Wellesley, MA (US) (2022)
Company Filing History:
2 out of 1,036 
1 out of 260 
Years Active: 2019-2022
Title: Innovations of Hongbo R Luo
Introduction
Hongbo R Luo is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medical technology, particularly in the treatment of lung infections and inflammation. With a total of 2 patents, his work showcases innovative approaches to addressing critical health issues.
Latest Patents
One of his latest patents is titled "Methods and compositions relating to the inhibition of IP6K1." This technology focuses on methods for treating lung infections and/or lung inflammation, such as pneumonia, by inhibiting the enzyme IP6K1. Another significant patent is "Supramolecular hydrogel of fMLF-based molecules and use thereof." This invention involves peptides that self-assemble to form supramolecular nanofibrils and hydrogels, along with hydrogel compositions that utilize these self-assembled structures.
Career Highlights
Throughout his career, Hongbo R Luo has worked with reputable organizations, including Children's Medical Center Corporation and Brandeis University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative medical solutions.
Collaborations
He has collaborated with notable colleagues, including Fan Zhao and Jingyu Li, which has further enriched his research endeavors.
Conclusion
Hongbo R Luo's contributions to medical technology through his patents and collaborations highlight his commitment to innovation in healthcare. His work continues to pave the way for advancements in the treatment of lung-related conditions.